U.S. Menopause Market Size & Outlook, 2025-2030

The menopause market in the United States is expected to reach a projected revenue of US$ 7,368.7 million by 2030. A compound annual growth rate of 4.9% is expected of the United States menopause market from 2025 to 2030.
Revenue, 2024 (US$M)
$5,556.2
Forecast, 2030 (US$M)
$7,368.7
CAGR, 2025 - 2030
4.9%
Report Coverage
U.S.

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

U.S. menopause market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

U.S. menopause market highlights

  • The U.S. menopause market generated a revenue of USD 5,556.2 million in 2024 and is expected to reach USD 7,368.7 million by 2030.
  • The U.S. market is expected to grow at a CAGR of 4.9% from 2025 to 2030.
  • In terms of segment, dietary supplements was the largest revenue generating treatment in 2024.
  • Dietary Supplements is the most lucrative treatment segment registering the fastest growth during the forecast period.

Menopause market data book summary

Market revenue in 2024USD 5,556.2 million
Market revenue in 2030USD 7,368.7 million
Growth rate4.9% (CAGR from 2025 to 2030)
Largest segmentDietary supplements
Fastest growing segmentDietary Supplements
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationHormonal, Non-Hormonal, Dietary Supplements
Key market players worldwideBayer AG, AbbVie Inc, Abbott Laboratories, Nestle SA, Dr Reddy's Laboratories Ltd ADR, Theramex, Rainbow Light Nutritional Systems, Padagis

Other key industry trends

  • In terms of revenue, U.S. accounted for 31.2% of the global menopause market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In North America, U.S. menopause market is projected to lead the regional market in terms of revenue in 2030.
  • Mexico is the fastest growing regional market in North America and is projected to reach USD 511.0 million by 2030.

Dietary supplements was the largest segment with a revenue share of 98.58% in 2024. Horizon Databook has segmented the U.S. menopause market based on hormonal, non-hormonal, dietary supplements covering the revenue growth of each sub-segment from 2018 to 2030.


As the millennial population is aging, the country has a large number of women entering menopause; around 6,000 women are expected to enter menopause each day in the U.S. According to a menopause survey conducted by AARP, a U.S.-based nonprofit organization, for its female members between the ages 60 and 69. Around 72% of women revealed that menopausal symptoms affected their lives and 8% of them admitted that the effects were extreme.

Key players in the region are conducting campaigns to create awareness about menopause and the role of dietary supplements in easing the transition through it. In September 2019, EQUELLE partnered with actress Kate Walsh for its campaign Live Hot, Stay Cool.

The campaign included sharing of menopauserelated experiences & tips by Kate with other women and the role that EQUELLE, a dietary supplement, played during the transition. The large number of menopausal women and initiatives undertaken to promote the use of dietary supplements during menopause are expected to contribute to the adoption of these products.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Menopause Market Companies

Name Profile # Employees HQ Website
Padagis View profile 251-500 Allegan, Michigan, United States, North America http://www.padagis.com
Rainbow Light Nutritional Systems View profile 51-100 Santa Cruz, California, United States, North America http://www.rainbowlight.com/
Theramex View profile 251-500 London, England, United Kingdom, Europe http://theramex.com/
Bayer AG View profile 99723 Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 https://www.bayer.com
Nestle SA View profile 270000 Avenue Nestle 55, Vevey, Switzerland, CH-1800 https://www.nestle.com
AbbVie Inc View profile 50000 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 http://www.abbvieinvestor.com
Dr Reddy's Laboratories Ltd ADR View profile 22822 8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, India, 500 034 https://www.drreddys.com
Abbott Laboratories View profile 114000 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 https://www.abbottinvestor.com

US Treatment - Menopause Market size, 2024 - 2030 (US$M)

U.S. Menopause Market Outlook Share, 2024 & 2030 (US$M)

US Treatment - Menopause Market size, 2024 - 2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online